|Day Low/High||6.02 / 6.37|
|52 Wk Low/High||5.13 / 9.20|
In trading on Monday, shares of Redhill Biopharma Ltd, Ramat Gan crossed above their 200 day moving average of $7.72, changing hands as high as $7.90 per share. Redhill Biopharma Ltd, Ramat Gan shares are currently trading up about 4.5% on the day.
Remembering these 'rules of the road' is vital in this highly volatile space.
Here's two 'rules of the road' when investing in this highly volatile space.
The Summit, N.J.-based firm said Thursday that it was discontinuing the GED-0301 (mongersen) Phase 3 Revolve study in Crohn's disease and the extension trial.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.